iSpecimen Inc. Other Nonoperating Expense
iSpecimen Inc. (ISPC) reported Other Nonoperating Expense of $9.17 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-02.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2023-11-02
- iSpecimen Inc. other nonoperating expense for the quarter ending 2023-09-30 was -$20.08K.
- iSpecimen Inc. other nonoperating expense for the quarter ending 2023-06-30 was $29.14K.
- iSpecimen Inc. other nonoperating expense for the quarter ending 2023-03-31 was $117.00.
- iSpecimen Inc. other nonoperating expense for the quarter ending 2021-12-31 was $22.77K.
- iSpecimen Inc. other nonoperating expense for fiscal 2021 was $44.53K.
| Period end | Other Nonoperating Expense 3 month | Other Nonoperating Expense 6 month | Other Nonoperating Expense 9 month | Other Nonoperating Expense 12 month |
|---|---|---|---|---|
| 2023-09-30 | -$20.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $9.06K derived: sum of 2 quarters · filed 2023-11-02 | $9.17K 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $29.14K 10-Q · filed 2023-08-02 | $29.25K 10-Q · filed 2023-08-02 | ||
| 2023-03-31 | $117.00 10-Q · filed 2023-05-04 | |||
| 2021-12-31 | $22.77K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-30 | $44.46K derived: sum of 2 quarters · filed 2023-03-30 | $44.53K 10-K/A · filed 2023-03-30 | |
| 2021-09-30 | $21.69K 10-Q · filed 2022-11-08 | $21.76K 10-Q · filed 2022-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |